ロード中...
Prolonged profound abciximab associated immune thrombocytopenia complicated by transient multispecific platelet antibodies
Patients receiving abciximab occasionally develop transient severe thrombocytopenia within a few hours of receiving the drug. Thrombocytopenia has been reported to resolve within 10 days of abciximab administration, but in this case profound thrombocytopenia lasted 21 days before a slow spontaneous...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Copyright 2004 by Heart
2004
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1768465/ https://ncbi.nlm.nih.gov/pubmed/15310724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2004.039040 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|